MyDrHank prices five preparations of three compounds compared here at flat monthly rates, and prices the needle and the needle-free form of two of them separately. Every one of those figures exists only after the page's scripts run: the address itself serves the same short shell for a real product and for a path that does not exist.
What MyDrHank charges
Sermorelin: $137/mo — "SermorelinRx ... From / $137 / /mo", read from the rendered page; the served HTML for this address contains none of it
NAD+: $155/mo — "NAD+ InjectionRx ... From / $155 / /mo" — the highest of the five rates this seller publishes, and the only one where the injection costs more than the nasal spray of the same compound
NAD+: $137/mo — "NAD+ Nasal SprayRx ... From / $137 / /mo"; the same page adds "Clinical evidence for nasal and injectable NAD+ delivery is limited."
Glutathione: $103/mo — "Glutathione InjectionRx ... From / $103 / /mo" — the same figure as this seller’s nasal preparation of the compound, so the two forms are priced identically today
Glutathione: $103/mo — "Glutathione Nasal SprayRx ... From / $103 / /mo", identical to the injectable form on the same catalogue
MyDrHank is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The address publishes nothing
Requesting any page on this host without running its scripts returns the same short application shell, byte for byte.
That is true of the homepage, of every product page, and of both nonsense paths fired as controls.
A check that compared served documents would have concluded that a real product and an invented one are the same page, and that neither publishes a price.
Every figure recorded here was read from the rendered page instead, where the product pages run to thousands of characters.
How the controls resolved once rendered
Rendered, a nonsense path at the root produces a genuine short not-found document.
A nonsense path under the product directory behaves differently: the router sends the reader to the homepage rather than rendering a product page for a slug that does not exist.
Neither behaviour fabricates a product, which is what the control was fired to rule out.
That difference between the two controls is worth recording, because a single control at the root would not have tested the product route at all.
Five rates, and two compounds priced twice
Three compounds this site tracks are sold here, two of them in both an injectable and a needle-free preparation.
The two forms of one compound carry the same figure today, while the two forms of the other do not, and the injectable is the more expensive of that pair.
Every figure is prefixed with the word from in the seller's own layout, so each is a floor rather than a settled charge, and the record says so on every row.
One of the pages states plainly that the clinical evidence for the routes it sells is limited, which is an unusual thing for a seller to volunteer.
No pharmacy, no footprint, no labs
The product pages describe compounding by a registered pharmacy and by accredited pharmacies; the terms describe licensed pharmacy partners.
All three are categories and none is a facility, so the pharmacy flag is false.
On states the terms say only that providers are licensed to practise where they treat patients, which is a tautology rather than a footprint.
No lab work is described as part of what is charged on any page read, so that flag is false on absence.
Who it's for
Readers comparing an injection against a nasal spray of the same compound at one seller.
Buyers who want a flat monthly rate rather than a prepaid plan.
Shoppers who value a seller volunteering that the evidence for a route is limited.
Anyone buying more than one of these three compounds together.
Who should look elsewhere
Readers who want a settled charge rather than a starting figure.
Buyers who need the compounding pharmacy named.
Anyone who needs to know whether their state is served before starting.
Shoppers who want lab work included in what they pay.
Strengths
Prices five preparations of three compounds at flat monthly rates on their own pages
Prices both a needle and a needle-free form of two compounds separately
Says on its own NAD+ pages that the clinical evidence for those routes is limited
Falls back to the homepage for an unknown product rather than rendering an empty product page
Trade-offs
Publishes nothing in the page itself — every figure exists only after its scripts run
Serves the identical document for a real product and for a path that does not exist
Prefixes every figure with "From", so none of the five is a settled charge
Names no compounding pharmacy on a product page or in its terms
How we verified this
Fetched every product address without scripts and confirmed all of them return the identical short shell, including a path that does not exist.
Rendered each product page in a browser and read every figure as laid-out text, because nothing is published in the document itself.
Fired two nonsense paths in the same pass and rendered both: one produced a genuine not-found document, the other redirected to the homepage rather than fabricating a product page.
Recorded that difference rather than firing a single control at the root, which would not have tested the product route.
Recorded the word preceding every figure, so no row reads as a settled charge when the seller calls it a floor.
Compared the two forms of each multi-form compound and recorded that one pair is priced identically and the other is not.
Read the terms for a named pharmacy and found only categories, matching the categories on the product pages.
Read the terms for a coverage claim and found a licensure tautology, so no states are stored.
Swept every rendered product page for a lab-work statement and found none.
Screened this seller in the live federal warning-letter record with a known-good positive control and a nonsense negative control fired in the same run, and read the company column of every returned record.
A provider to compare MyDrHank against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.